[1]
|
Cancer Genome Atlas Network (2012) Comprehensive Molecular Portraits of Human Breast Tumours. Nature, 490, 61-70. http://dx.doi.org/10.1038/nature11412
|
[2]
|
Ibrahim, A.S., Khaled, H.M., Mikhail, N.N.H., Baraka, H. and Kamel, H. (2014) Cancer Incidence in Egypt: Results of the National Population-Based Cancer Registry Program. Journal of Cancer Epidemiology, 2014, Article ID: 437971.
http://dx.doi.org/10.1155/2014/437971
|
[3]
|
Karina, B., Hirata, B., Oda, J.M.M., Guembarovski, R.L., Ariza, C.B., de Oliveira, C.E.C. and Watanabe, M.A.E. (2014) Molecular Markers for Breast Cancer: Prediction on Tumor Behavior. Disease Markers, 2014, Article ID: 513158. http://dx.doi.org/10.1155/2014/513158
|
[4]
|
Jung, S., Yi, L.S., Kim, J.S., Jeong, D.J., Oh, T., Kim, C.-H., Kim, C.-J., Shin, J., An, S. and Lee, M.-S. (2011) The Role of Vimentin as a Methylation Biomarker for Early Diagnosis of Cervical Cancer. Molecules and Cells, 31, 405-411.
|
[5]
|
Fleischer, T., Frigessi, A., Johnson, K.C., et al. (2014) Genome-Wide DNA Methylation Profiles in Progression to in Situ and Invasive Carcinoma of the Breast with Impact on Gene Transcription and Prognosis. Genome Biology, 15, 435.
|
[6]
|
Fleischer, T., Edvardsen, H., Solvang, H.K., et al. (2014) Integrated Analysis of High-Resolution DNA Methylation Profiles, Gene Expression, Germline Genotypes and Clinical End Points in Breast Cancer Patients. International Journal of Cancer, 134, 2615-2625.
http://dx.doi.org/10.1002/ijc.28606
|
[7]
|
Jovanovic, J., Ronneberg, J.A., Tost, J., et al. (2010) The Epigenetics of Breast Cancer. Molecular Oncology, 4, 242-254. http://dx.doi.org/10.1016/j.molonc.2010.04.002
|
[8]
|
Kallerg, G., Papadak, M.A., Politaki, E., Mavroudis, D., Georgoulias, V. and Agelaki, S. (2011) Epithelial to Mesenchymal Transition Markers Expressed in Circulating Tumour Cells of Early and Metastatic Breast Cancer Patients. Breast Cancer Research, 13, 59.
http://dx.doi.org/10.1186/bcr2896
|
[9]
|
Ulirsch, J., Fan, C., Knafl, G., Wu, M.J., Coleman, B., Perou, C.M. and Swift-Scanlan, T. (2013) Vimentin DNA Methylation Predicts Survival in Breast Cancer. Breast Cancer Research and Treatment, 137, 383-396. http://dx.doi.org/10.1007/s10549-012-2353-5
|
[10]
|
Fackler, M.J., Umbricht, C.B., Williams, D., Argani, P., Cruz, L.A., Merino, V.F., Teo, W.W., Zhang, Z., Huang, P., Visvananthan, K., Marks, J., Ethier, S., Gray, J.W., Wolff, A.C., Cope, L.M. and Sukumar, S. (2011) Genome-Wide Methylation Analysis Identifies Genes Specific to Breast Cancer Hormone Receptor Status and Risk of Recurrence. Cancer Research, 71, 6195-6207. http://dx.doi.org/10.1158/0008-5472.CAN-11-1630
|
[11]
|
Itzkowitz, S.H., Jandorf, L., Brand, R., Rabeneck, L., Schroy, P.C., Sontag, S., Johnson, D., Skoletsky, J., Durkee, K., Markowitz, S. and Shuber, A. (2007) Improved Fecal DNA Test for Colorectal Cancer Screening. Clinical Gastroenterology and Hepatology, 5, 111-117.
http://dx.doi.org/10.1016/j.cgh.2006.10.006
|
[12]
|
Kitamura, Y.H., Shirahata, A., Sakata, M., Goto, T., Mizukami, H., Saito, M., Ishibashi, K., Kigawa, G., Nemoto, H., Sanada, Y. and Hibi, K. (2009) Frequent Methylation of Vimentin in Well-Differentiated Gastric Carcinoma. Anticancer Research, 29, 2227-2229.
|
[13]
|
Costa, V.L., Henrique, R., Danielsen, S.A., Duarte-Pereira, S., Eknaes, M., Skotheim, R.I., Rodrigues, A., Magalhaes, J.S., Oliveira, J., Lothe, R.A., Teixeira, M.R., Jeronimo, C. and Lind, G.E. (2010) Three Epigenetic Biomarkers, GDF15, TMEFF2, and, VIM, Accurately Predict Bladder Cancer from DNA-Based Analyses of Urine Samples. Clinical Cancer Research, 16, 5842-5851. http://dx.doi.org/10.1158/1078-0432.CCR-10-1312
|
[14]
|
Zhou, Y.F., Xu, W., Wang, X., Sun, J.S., Xiang, J.J., Li, Z.S. and Zhang, X.F. (2014) Negative Methylation Status of Vimentin Predicts Improved Prognosis in Pancreatic Carcinoma. World Journal of Gastroenterology, 20, 13172-13177.
http://dx.doi.org/10.3748/wjg.v20.i36.13172
|
[15]
|
Edge, S.B. (2010) Breast. In: Edge, S.B., Byrd, D.R. and Compton, C.C., Eds., AJCC Cancer Staging Manual, 7th Edition, Springer, New York, 347-376.
|
[16]
|
Tokunaga, E., Kimura, Y., Oki, E., Ueda, N., Futatsugi, M., Mashino, K., Yamamoto, M., Ikebe, M., Kakeji, Y., Baba, H. and Maehara, Y. (2006) Akt Is Frequently Activated in HER2/Neu-Positive Breast Cancers and Associated with Poor Prognosis among Hormone-Treated Patients. International Journal of Cancer, 118, 284-289.
http://dx.doi.org/10.1002/ijc.21358
|
[17]
|
Wong, I.H., Lo, Y.M., Zhang, J., Liew, C.T., Ng, M.H., Wong, N., et al. (1999) Detection of Aberrant P16 Methylation in the Plasma and Serum of Liver Cancer Patients. Cancer Research, 59, 71-73.
|
[18]
|
Tiwari, S.K., Manoj, G., Prasanth, K., Sivaram, G., Sharma, V.K., Habeeb, M.A., et al. (2009) Simplified and Versatile Method for Bisulfite-Based DNA Methylation Analysis of Small Amounts of DNA. Journal of Clinical Laboratory Analysis, 23, 172-174.
http://dx.doi.org/10.1002/jcla.20314
|
[19]
|
Kitamura, Y., Shirahata, A., Sakuraba, K., Goto, T., Mizukami, H., Saito, M., et al. (2011) Aberrant Methylation of the Vimentin Gene in Hepatocellular Carcinoma. Anticancer Research, 31, 1289-1291.
|
[20]
|
Moinova, H., Leidner, R.S., Ravi, L., Lutterbaugh, J., Barnholtz-Sloan, J.S., Chen, Y., Chak, A., Markowitz, S.D. and Willis, J.E. (2012) Aberrant Vimentin Methylation Is Characteristic of Upper Gastrointestinal Pathologies. Cancer Epidemiology Biomarkers & Prevention, 21, 594-600. http://dx.doi.org/10.1158/1055-9965.EPI-11-1060
|
[21]
|
Shirahata, A., Sakata, M., Sakuraba, K., Goto, T., Mizukami, H., Saito, M., Ishibashi, K., Kigawa, G., Nemoto, H. and Sanada, Y. (2009) Vimentin Methylation as a Marker for Advanced Colorectal Carcinoma. Anticancer Research, 29, 279-281.
|
[22]
|
Wong, K.F. and Luk, J.M. (2012) Discovery of Lamin b1 and Vimentin as Circulating Biomarkers for Early Hepatocellular Carcinoma. Methods in Molecular Biology, 909, 295-310.
|
[23]
|
Rybarova, S., Vecanova, J., Hodorova, I., et al. (2011) Association between Polymorphisms of XRCC1, p53 and MDR1 Genes, the Expression of Their Protein Products and Prognostic Significance in Human Breast Cancer. Medical Science Monitor, 17, 354-363.
http://dx.doi.org/10.12659/MSM.882121
|
[24]
|
Tvrdik, D., Skalova, H., Dundr, P., et al. (2012) Apoptosis—Associated Genes and Their Role in Predicting Responses to Neoadjuvant Breast Cancer Treatment. Medical Science Monitor, 18, 60-67. http://dx.doi.org/10.12659/MSM.882205
|
[25]
|
Liu, Y., Zhao, J., Zhang, P., Zhang, Y., Sun, S., Yu, S. and Xi, Q. (2012) MicroRNA-10b Targets E-Cadherin and Modulates Breast Cancer Metastasis. Medical Science Monitor, 18, 299-308. http://dx.doi.org/10.12659/MSM.883262
|
[26]
|
Satelli, A. and Li, S. (2011) Vimentin as a Potential Molecular Target in Cancer Therapy or Vimentin, an Overview and Its Potential as a Molecular Target for Cancer Therapy. Cellular and Molecular Life Sciences, 68, 3033-3046.
http://dx.doi.org/10.1007/s00018-011-0735-1
|
[27]
|
Gyorffy, B., Bottai, G., Fleischer, T., Munkacsy, G., Budczies, J., Paladini, L., et al. (2016) Aberrant DNA Methylation Impacts Gene Expression and Prognosis in Breast Cancer Subtypes. International Journal of Cancer, 138, 87-97. http://dx.doi.org/10.1002/ijc.29684
|
[28]
|
Yamashita, N., Tokunaga, E., Kitao, H., Hisamatsu, Y., Taketani, K., Akiyoshi, S., et al. (2013) Vimentin as a Poor Prognostic Factor for Triple-Negative Breast Cancer. Journal of Cancer Research and Clinical Oncology, 139, 739-746.
http://dx.doi.org/10.1007/s00432-013-1376-6
|
[29]
|
Karihtala, P., Auvinen, P., Kauppila, S., Haapasaari, K.M., Jukkola-Vuorinen, A. and Soini, Y. (2013) Vimentin, Zeb1 and Sip1 Are Up-Regulated in Triple-Negative and Basal-Like Breast Cancers: Association with an Aggressive Tumour Phenotype. Breast Cancer Research and Treatment, 138, 81-90. http://dx.doi.org/10.1007/s10549-013-2442-0
|
[30]
|
Mor-Vaknin, N., Sitwala, K. and Markovitz, D.M. (2003) Vimentin Is Secreted by Activated Macrophages. Nature Cell Biology, 5, 59-63. http://dx.doi.org/10.1038/ncb898
|
[31]
|
Kallergi, G., Politaki, E., Mavroudis, D., Georgoulias, V. and Agelaki, S. (2011) Epithelial to Mesenchymal Transition Markers Expressed in Circulating Tumor Cells of Early and Metastatic Breast Cancer Patients. Breast Cancer Research, 13, R59.
http://dx.doi.org/10.1186/bcr2896
|
[32]
|
Chaffer, C.L., Brennan, J.P., Slavin, J.L., Blick, T., Thompson, E.W. and Williams, E.D. (2006) Mesenchymal-to-Epithelial Transition Facilitates Bladder Cancer Metastasis: Role of Fibroblast Growth Factor Receptor-2. Cancer Research, 66, 11271-11278.
http://dx.doi.org/10.1158/0008-5472.CAN-06-2044
|
[33]
|
Gjerdrum, C., Tiron, C., Hoiby, T., Stefansson, I., Haugen, H., Sandal, T., Collett, K., Li, S., McCormack, E., Gjertsen, B.T., Micklem, D.R., Akslen, L.A., Glackin, C. and Lorens, J.B. (2010) Axl Is an Essential Epithelial-to-Mesenchymal Transition-Induced Regulator of Breast Cancer Metastasis and Patient Survival. Proceedings of the National Academy of Sciences of the United States of America, 107, 1124-1129.
http://dx.doi.org/10.1073/pnas.0909333107
|
[34]
|
Holland, S.J., Powell, M.J., Franci, C., Chan, E.W., Friera, A.M., Atchison, R.E., McLaughlin, J., Swift, S.E., Pali, E.S., Yam, G., Wong, S., Lasaga, J., Shen, M.R., Yu, S., Xu, W., Hitoshi, Y., Bogenberger, J., Nor, J.E., Payan, D.G. and Lorens, J.B. (2005) Multiple Roles for the Receptor Tyrosine Kinase Axl in Tumor Formation. Cancer Research, 65, 9294-9303.
http://dx.doi.org/10.1158/0008-5472.CAN-05-0993
|
[35]
|
Fuyuhiro, Y., Yashiro, M., Noda, S., Kashiwagi, S., Matsuoka, J., Doi, Y., et al. (2010) Clinical Significance of Vimentin-Positive Gastric Cancer Cells. Anticancer Research, 30, 5239-5243.
|
[36]
|
Jin, H., Morohashi, S., Sato, F., Kudo, Y., Akasaka, H., Tsutsumi, S., et al. (2010) Vimentin Expression of Esophageal Squamous Cell Carcinoma and Its Aggressive Potential for Lymph Node Metastasis. BioMed Research, 31, 105-112.
http://dx.doi.org/10.2220/biomedres.31.105
|
[37]
|
Alfonso, P., Nunez, A., Madoz-Gurpide, J., Lombardia, L., Sanchez, L. and Casal, J.I. (2005) Proteomic Expression Analysis of Colorectal Cancer by Two-Dimensional Differential Gel Electrophoresis. Proteomics, 5, 2602-2611. http://dx.doi.org/10.1002/pmic.200401196
|
[38]
|
McInroy, L. and Maatta, A. (2007) Down-Regulation of Vimentin Expression Inhibits Carcinoma Cell Migration and Adhesion. Biochemical and Biophysical Research Communications, 360, 109-114. http://dx.doi.org/10.1016/j.bbrc.2007.06.036
|
[39]
|
Hong, S.H., Misek, D.E., Wang, H., Puravs, E., Hinderer, R., Giordano, T.J., et al. (2006) Identification of a Specific Vimentin Isoform That Induces an Antibody Response in Pancreatic Cancer. Biomarker Insights, 1, 175-183.
|
[40]
|
Walsh, N., O’Donovan, N., Kennedy, S., Henry, M., Meleady, P., Clynes, M., et al. (2009) Identification of Pancreatic Cancer Invasion-Related Proteins by Proteomic Analysis. Proteome Science, 7, 3. http://dx.doi.org/10.1186/1477-5956-7-3
|
[41]
|
Korsching, E., Packeisen, J., Liedtke, C., Hungermann, D., Wulfing, P., van Diest, P.J., et al. (2005) The Origin of Vimentin Expression in Invasive Breast Cancer: Epithelial-Mesenchymal Transition, Myoepithelial Histogenesis or Histogenesis from Progenitor Cells with Bilinear Differentiation Potential. Journal of Pathology, 206, 451-457.
http://dx.doi.org/10.1002/path.1797
|
[42]
|
Li, M., Zhang, B., Sun, B., Wang, X., Ban, X., Sun, T., et al. (2010) A Novel Function for Vimentin: The Potential Biomarker for Predicting Melanoma Hematogenous Metastasis. Journal of Experimental and Clinical Cancer Research, 29, 109.
http://dx.doi.org/10.1186/1756-9966-29-109
|
[43]
|
Fortin, S., Le Mercier, M., Camby, I., Spiegl-Kreinecker, S., Berger, W., Lefranc, F., et al. (2010) Galectin-1 Is Implicated in the Protein Kinase C Epsilon/Vimentin-Controlled Trafficking of Integrin-Beta1 in Glioblastoma Cells. Brain Pathology, 20, 39-49.
http://dx.doi.org/10.1111/j.1750-3639.2008.00227.x
|
[44]
|
Li, Z.M., Wen, Y.J., Yang, H.B., Qin, G., Tian, L., Deng, H.X., et al. (2008) Enhanced Expression of Human Vimentin Intermediate Filaments in Hepatocellular Carcinoma Cells Decreases Their Proliferative and Invasive Abilities in Vitro. Chinese Journal of Oncology, 30, 408-412.
|
[45]
|
Bouamrani, A., Ramus, C., Gay, E., Pelletier, L., Cubizolles, M., Brugiere, S., et al. (2010) Increased Phosphorylation of Vimentin in Noninfiltrative Meningiomas. PLoS ONE, 5, e9238. http://dx.doi.org/10.1371/journal.pone.0009238
|
[46]
|
Chen, W., Han, Z.J., Skoletsk, J., Olson, J., Sah, J., Myeroff, L., et al. (2005) Detection in Fecal DNA of Colon Cancer-Specific Methylation of the Nonexpressed Vimentin Gene. Journal of the National Cancer Institute, 97, 1124-1132.
http://dx.doi.org/10.1093/jnci/dji204
|